S'abonner

OCCUPATIONAL HEPATOTOXICITY - 09/09/11

Doi : 10.1016/S1089-3261(05)70027-1 
Keith G. Tolman, MD a, Robert W. Sirrine, MSPH b
a Division of Gastroenterology, Department of Internal Medicine (KGT) 
b Division of Occupational and Environmental Health, Department of Family and Preventative Medicine (RWS), University of Utah School of Medicine, Salt Lake City, Utah 

Résumé

All foreign chemicals are capable, at sufficient concentrations, of producing harmful effects on living tissues. From the time of the Industrial Revolution through most of this century, man ignored the spilling of chemicals into the workplace and the environment. Alice Hamilton, the matriarch of industrial medicine and the first woman on the Harvard faculty, was the first American physician to devote a career to industrial medicine. In her autobiography, she commented, “American medical authorities had never taken industrial disease seriously … The employers could, if they wished, shut their eyes to the dangers their workers faced, for nobody held them responsible, while the workers accepted the risks with fatalistic submissiveness as part of the price one must pay for being poor.”23 It would take the enlightened and somewhat startling observations of Rachel Carson in her 1962 book Silent Spring6 to awaken the general public, industry, and the scientific world. Twenty-six years later, Hyman Zimmerman90 commented that

The issues have been clouded, however, by the incompleteness of the database, and the judgements are compromised by the efforts to balance the potential and proved adverse effects of many pollutants against the important, sociologic, economic, and medical benefits… . Containment of the risks posed by environmental contamination requires systematic and coordinated epidemiologic, toxicologic and clinical studies to set the stage for the proper control measures.

Although many of the toxicologic studies have been completed and have led to the eventual removal of some industrial toxins, epidemiologic and clinical studies are still lacking. In fact, fewer than 30% of currently available and potential hepatotoxic chemicals have been studied adequately (more on that later). Dr Zimmerman's comments remain applicable almost one decade later. We continue to have toxic exposures to known hepatotoxins, such as vinyl chloride56 and yet-to-be-identified hepatotoxins spilling into the environment. A recent observation of nonalcoholic steatohepatitis (NASH) in workers in the petrochemical industry in Brazil, and the resolution of NASH when the workers were moved from the industrial area, is yet another reminder that all is not well.12, 13

Science continues to be compromised by the lack of good models to predict toxicity; the employment of mostly acute rather than chronic studies; and the persistence of economic, social, medical, and political forces, whose diverse priorities have made it difficult to achieve balance. It seems self-evident that a person's health is, in a large part, a function of the health of his or her environment. But even in retrospect, as Dr Zimmerman pointed out, it would be difficult to weigh the benefits of the insecticide dichlorodiphenyltrichloroethane (DDT) against its adverse effects. Although it had devastating effects on wildlife and created havoc with various ecosystems, DDT played a major role in improving the health of that environment by eradicating malaria and enhancing food production in the world.

The important developments in the understanding of metabolic activation of chemicals and the consequences of activation on the interaction of multiple pollutants is just beginning to be recognized. The problem is compounded by the fact that experimental animals have not been highly predictive of human toxicity. A good example was trinitrotoluene (TNT), which was reported to be toxic in 1916,38 but toxicity could be shown in animals only after extreme manipulation.24 There also is the problem of acute versus chronic exposure, which may not only have different effects but effects on different target organs. For example, acute exposure to polychlorinated bipheynls primarily involves the skin, although chronic exposure affects primarily the liver. Most models of toxicity test for acute exposure because it is difficult and expensive to test for toxicity to chronic exposure. Despite current shortcoming in methodology, it is no longer possible to introduce a chemical without prior biologic testing. Acceptable exposure limits have been defined by the Occupational Health and Safety Administration. Most important, reports of industrial hepatotoxicity are now rare. Nevertheless, the latency period between exposure and the development of significant toxicity, as well as the persistence of injury after discontinuing exposure (e.g., vinyl chloride), are a constant reminder of the need for vigilance.25

The compilation of central databases has helped enormously in making information accessible to the medical, lay, and industrial communities. We have relied on some of these databases in compiling this article.24548, 5481

This article reviews the mechanisms of injury and exposure, the occupations at risk, the categories of chemicals, and some specific examples of industrial hepatotoxins. It also includes references to information and regulations about industrial toxins.

Le texte complet de cet article est disponible en PDF.

Plan


 Address reprint requests to Keith G. Tolman, MD, Division of Gastroenterology, Department of Internal Medicine, 50 North Medical Drive, Salt Lake City, UT 84132, e-mail: tolman@gas.med.utah.edu


© 1998  W. B. Saunders Company. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 2 - N° 3

P. 563-589 - août 1998 Retour au numéro
Article précédent Article précédent
  • NSAID-INDUCED HEPATOTOXICITY
  • James H. Lewis
| Article suivant Article suivant
  • DRUG-INDUCED HEPATIC VASCULAR ABNORMALITIES
  • Norman Gitlin

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.